May 11, 2017 / 5:18 PM / 2 months ago

BRIEF-Boston Scientific announces results of study evaluating patients implanted with S-ICD System

1 Min Read

May 11 (Reuters) - Boston Scientific Corp:

* Announced results from U.S. post-market approval study evaluating 'real-world' patients implanted with S-ICD System

* Acute results for S-ICD System show therapy effectively terminated life-threatening heart arrhythmias in 98.7% evaluated patients

* S-ICD System analysis also validated low complication rates, with a complication-free rate of 96.2 percent at 30 days post-procedure Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below